ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,664Medicare Part D Prescriptions Filled, Including Refills

Rank: 111 out of 1290

$620K Total Retail Price of All Prescriptions

Rank: 130 out of 1290

522 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 522 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 522 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 7,242 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$81 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 408 395 1 1
AMLODIPINE BESYLATE 356 355 2 3
ZOLPIDEM TARTRATE 217 212 3 15
METOPROLOL TARTRATE 199 190 4 7
CRESTOR 198 182 5 17
CLOPIDOGREL 192 190 6 24
ATORVASTATIN CALCIUM 188 187 7 23
LEVOTHYROXINE SODIUM 179 174 8 4
PLAVIX 166 166 9 32
FUROSEMIDE 159 141 10 9
AZITHROMYCIN 136 129 11 61
METOPROLOL SUCCINATE 133 128 12 14
DIOVAN 129 129 13 53
WARFARIN SODIUM 125 125 14 22
LOSARTAN POTASSIUM 123 121 15 19
LISINOPRIL 119 119 16 5
TRIAMTERENE-HCTZ 113 112 17 130
ZETIA 108 100 18 165
OMEPRAZOLE 100 87 19 2
RANEXA 94 93 20 258
LIPITOR 89 89 21 195
HYDROCHLOROTHIAZIDE 86 64 22 20
POTASSIUM CHLORIDE 83 76 23 35
SYNTHROID 81 81 24 28
NEXIUM 79 79 25 34
CARVEDILOL 78 72 26 12
TAMSULOSIN HCL 77 77 27 11
LOSARTAN-HYDROCHLOROTHIAZIDE 74 64 28 106
HYDROCODONE-ACETAMINOPHEN 71 26 S3 29 6
ESCITALOPRAM OXALATE 70 70 30 63
ISOSORBIDE MONONITRATE ER 69 69 31 58
METFORMIN HCL 65 56 32 10
DONEPEZIL HCL 64 64 33 13
PANTOPRAZOLE SODIUM 63 63 34 48
FINASTERIDE 63 63 34 40
SOTALOL 62 62 36 226
LEXAPRO 61 61 37 173
CELEBREX 61 49 37 111
SPIRONOLACTONE 58 58 39 126
RAMIPRIL 54 54 40 136
CITALOPRAM HBR 52 52 41 29
PREDNISONE 52 52 41 21
ATENOLOL 51 51 43 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 28, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.